7 Notable Companies Empowering Women’s Health with AI
With over half of the world's population being female, it's only natural that the world of femtech is experiencing a tremendous surge of interest. The numbers speak volumes. A recent research report by Global Market Insights predicts that the femtech market will soar beyond $48.5 billion by 2025. This exciting growth is fueled by the innovative integration of cutting-edge technologies such as tracking wearables, artificial intelligence (AI), intuitive apps, and noninvasive hardware, all aimed at revolutionizing female health and well-being.
Back in 2016, Ida Tin, the CEO behind the renowned period-tracking app Clue, introduced the term "FemTech" to capture the wave of startups pushing the boundaries of technology in the realm of female health. Today, the term encompasses an even wider range of innovative solutions aimed at enhancing every aspect of women's lives.
For far too long, the physiological differences between men and women have been overlooked, despite women constituting half of the population. Fortunately, the rise of femtech has unleashed a wave of empowerment, ensuring that women no longer settle for the status quo. Here we present eight notable AI-powered companies working in the field of fem tech.
1. Ava
Ava is the ideal companion for women who are trying to get pregnant and want to make the most of their chances to conceive, as well as for women who want to get to know their bodies and cycle better. Recognized as an FDA-approved fertility tracking wearable device, Ava revolutionizes the way women approach family planning. Worn during sleep, the Ava bracelet harnesses the power of machine learning algorithms to track five physiological signals. It measures nine physiological parameters and thus predicts a woman’s next fertile window and ovulation precisely and conveniently. Ava has been shown to detect an average of 5.3 fertile days per cycle at 89% accuracy. It was clinically tested in a year-long study at the University Hospital of Zurich, and the first findings were published in the peer-reviewed journal Scientific Reports. Ava is an FDA-registered device and CE-certified. The company has raised a total of $42.4 million in funding over 8 rounds, with their latest funding raised in May 2018 from a Series B round.
Continue reading
This content available exclusively for BPT Mebmers
We use cookies to personalise content and to analyse our traffic.
You consent to our cookies if you continue to use our website. Read more details in our
cookies policy.